SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-040971
Filing Date
2022-11-10
Accepted
2022-11-10 16:39:50
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10043809_10q.htm   iXBRL 10-Q 2047838
2 EXHIBIT 31.1 brhc10043809_ex31-1.htm EX-31.1 11794
3 EXHIBIT 31.2 brhc10043809_ex31-2.htm EX-31.2 12146
4 EXHIBIT 32.1 brhc10043809_ex32-1.htm EX-32.1 5156
5 EXHIBIT 32.2 brhc10043809_ex32-2.htm EX-32.2 5243
  Complete submission text file 0001140361-22-040971.txt   7232499

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA knte-20220930.xsd EX-101.SCH 36275
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE knte-20220930_cal.xml EX-101.CAL 55095
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE knte-20220930_def.xml EX-101.DEF 188695
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE knte-20220930_lab.xml EX-101.LAB 524524
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knte-20220930_pre.xml EX-101.PRE 341594
58 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043809_10q_htm.xml XML 1167111
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39743 | Film No.: 221377971
SIC: 2834 Pharmaceutical Preparations